Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
90.14
+1.21 (1.36%)
At close: Dec 20, 2024, 4:00 PM
90.00
-0.14 (-0.16%)
After-hours: Dec 20, 2024, 4:55 PM EST
Blueprint Medicines Analyst Ratings
Total Analysts
20
Consensus Rating
Buy
Price Target
$120.79
Upside
+34.00%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +38.67% | Dec 9, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +38.67% | Nov 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +49.77% | Nov 15, 2024 |
Needham | Needham | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +49.77% | Nov 15, 2024 |
JP Morgan | JP Morgan | Buy Initiates $126 | Buy | Initiates | $126 | +39.78% | Nov 14, 2024 |
Wells Fargo | Wells Fargo | Buy Maintains $153 → $151 | Buy | Maintains | $153 → $151 | +67.52% | Oct 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +49.77% | Oct 31, 2024 |
Needham | Needham | Strong Buy Maintains $133 → $135 | Strong Buy | Maintains | $133 → $135 | +49.77% | Oct 31, 2024 |
Needham | Needham | Strong Buy Reiterates $133 | Strong Buy | Reiterates | $133 | +47.55% | Oct 30, 2024 |
UBS | UBS | Hold Initiates $88 | Hold | Initiates | $88 | -2.37% | Oct 24, 2024 |
Needham | Needham | Strong Buy Maintains $130 → $133 | Strong Buy | Maintains | $130 → $133 | +47.55% | Aug 5, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $130 → $138 | Strong Buy | Maintains | $130 → $138 | +53.10% | Aug 2, 2024 |
Baird | Baird | Buy Maintains $112 → $127 | Buy | Maintains | $112 → $127 | +40.89% | Aug 2, 2024 |
Needham | Needham | Strong Buy Reiterates $130 | Strong Buy | Reiterates | $130 | +44.22% | Aug 1, 2024 |
Barclays | Barclays | Hold Maintains $75 → $105 | Hold | Maintains | $75 → $105 | +16.49% | Jul 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.